Market Research Logo

Type 1 Diabetes Pipeline Highlights – 2017 Update

Type 1 Diabetes Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Type 1 Diabetes Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Type 1 Diabetes market. It covers emerging therapies for Type 1 Diabetes in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Type 1 Diabetes pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Type 1 Diabetes pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Type 1 Diabetes pipeline products by the company.

Short-term Launch Highlights:
Find out which Type 1 Diabetes pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • Type 1 Diabetes phase 3 clinical trial pipeline products
  • Type 1 Diabetes phase 2 clinical trial pipeline products
  • Type 1 Diabetes phase 1 clinical trial pipeline products
  • Type 1 Diabetes preclinical research pipeline products
  • Type 1 Diabetes discovery stage pipeline products
  • Type 1 Diabetes pipeline products short-term launch highlights


1. Type 1 Diabetes Pipeline by Stages
2. Type 1 Diabetes Pipeline by Drug Class
3. Type 1 Diabetes Pipeline by Company
4. Type 1 Diabetes Phase 3 Clinical Trial Insights
5. Type 1 Diabetes Phase 2 Clinical Trial Insights
6. Type 1 Diabetes Phase 1 Clinical Trial Insights
7. Type 1 Diabetes Preclinical Research Insights
8. Type 1 Diabetes Discovery Stage Insights
9. Appendix
10. Research Methodology
LIST OF TABLES
Table 1: Type 1 Diabetes Phase 3 Clinical Trials, 2017
Table 2: Type 1 Diabetes Phase 2 Clinical Trials, 2017
Table 3: Type 1 Diabetes Phase 1 Clinical Trials, 2017
Table 4: Type 1 Diabetes Preclinical Research, 2017
Table 5: Type 1 Diabetes Discovery Stage, 2017
LIST OF FIGURES
Figure 1: Type 1 Diabetes Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: Type 1 Diabetes Pipeline Molecules by Drug Class, 2017
Figure 3: Type 1 Diabetes Pipeline Molecules by Company, 2017
Figure 4: Type 1 Diabetes Phase 3 Clinical Trial Highlights, 2017
Figure 5: Type 1 Diabetes Phase 2 Clinical Trial Highlights, 2017
Figure 6: Type 1 Diabetes Phase 1 Clinical Trial Highlights, 2017
Figure 7: Type 1 Diabetes Preclinical Research Highlights, 2017
Figure 8: Type 1 Diabetes Discovery Stage Highlights, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report